Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule

Affiliations

¹ Department of Medical Microbiology, University Hospital RWTH Aachen, German National Reference Center for Streptococci, Aachen 52074, Germany. Electronic address: sperniciaro@ukaachen.de.
² Department of Medical Microbiology, University Hospital RWTH Aachen, German National Reference Center for Streptococci, Aachen 52074, Germany.

Comment

Stephanie Perniciaro et al. Lancet Infect Dis. 2018 Apr.

. 2018 Apr;18(4):381-382.

doi: 10.1016/S1473-3099(18)30129-4. Epub 2018 Mar 21.

¹ Department of Medical Microbiology, University Hospital RWTH Aachen, German National Reference Center for Streptococci, Aachen 52074, Germany. Electronic address: sperniciaro@ukaachen.de.
² Department of Medical Microbiology, University Hospital RWTH Aachen, German National Reference Center for Streptococci, Aachen 52074, Germany.

No abstract available

Comment in

Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule - Authors' reply.
Goldblatt D, Miller E. Goldblatt D, et al. Lancet Infect Dis. 2018 Apr;18(4):382-383. doi: 10.1016/S1473-3099(18)30168-3. Epub 2018 Mar 21. Lancet Infect Dis. 2018. PMID: 29582766 No abstract available.

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.
Goldblatt D, Southern J, Andrews NJ, Burbidge P, Partington J, Roalfe L, Valente Pinto M, Thalasselis V, Plested E, Richardson H, Snape MD, Miller E. Goldblatt D, et al. Lancet Infect Dis. 2018 Feb;18(2):171-179. doi: 10.1016/S1473-3099(17)30654-0. Epub 2017 Nov 22. Lancet Infect Dis. 2018. PMID: 29174323 Free PMC article. Clinical Trial.